GO:1990349 gap junction-mediated intercellular transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990349 describes the movement of ions and small molecules between adjacent animal cells through gap junction channels.
• Gap junctions are formed by connexin proteins that dock across apposed plasma membranes to create aqueous pores.
• This transport process is central to tissue coordination, immune signaling, and responses to stress such as cisplatin ototoxicity.
• Pathogens and inflammatory cues can remodel or inhibit gap junction-mediated intercellular communication.
• Dysregulation of gap junction transport is implicated in atherosclerosis, pain, fibrosis, and cancer-related EMT.
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of connexin-dependent transport.
Description
Gap junction-mediated intercellular transport (GO:1990349) is the biological process by which substances move directly between the cytoplasm of adjacent animal cells through gap junction channels. These channels are fine cytoplasmic conduits that allow ions and other small molecules to pass freely, coupling cells electrically and metabolically. Unlike vesicular or transporter-mediated secretion, this process bypasses the extracellular space and provides a rapid route for signal propagation and metabolic sharing. The term is therefore fundamental to understanding how tissues coordinate responses without relying solely on paracrine or endocrine signals. Researchers study GO:1990349 because it underlies diverse physiological and pathological outcomes, from immune cell communication to drug-induced hearing loss and viral infection. For example, gap junction-mediated transfer of cAMP protects against cisplatin-induced ototoxicity via the cAMP/PKA/CREB pathway. In the immune system, gap junctions facilitate intercellular communication that shapes antigen presentation and immune responses. In the cornea, poly(I:C) inhibits gap junction-mediated intercellular communication in cultured human corneal fibroblasts, linking innate immune activation to reduced coupling. Human coronavirus OC43 infection remodels connexin 43-mediated gap junction intercellular communication in vitro, showing that pathogens can directly target this process. Because the process is so broadly relevant, precise experimental models are needed to determine which connexins and regulatory pathways are causally involved.
gap junction-mediated intercellular transport At A Glance
| GO ID | GO:1990349 |
|---|---|
| GO term | gap junction-mediated intercellular transport |
| Ontology | biological_process |
| Synonym | none |
| Definition | The movement of substances between cells via gap junctions, which are fine cytoplasmic channels connecting the cytoplasm of adjacent animal cells and allowing ions and other molecules to pass freely. |
| Major function | Direct cytoplasmic exchange of ions and small molecules between adjacent cells. |
| Cellular structures involved | Gap junction channels composed of connexin proteins. |
| Representative regulators | Connexin 43 and other connexins; cAMP/PKA/CREB signaling. |
| Disease relevance | Ototoxicity, viral infection, atherosclerosis, pain, EMT, immune dysfunction. |
What Is GO:1990349?
GO:1990349 is defined as the movement of substances between cells via gap junctions, where a gap junction is a fine cytoplasmic channel found in animal cells that connects the cytoplasm of one cell to that of an adjacent cell, allowing ions and other molecules to pass freely between the two cells. In practice, this means the process encompasses the directed or passive transfer of small cytosolic molecules through connexin-based channels, rather than through membrane transporters or vesicular release.
Why Is gap junction-mediated intercellular transport Important in Cell Biology?
GO:1990349 is important because it provides a direct, channel-mediated route for intercellular communication that is distinct from synaptic, paracrine, and endocrine signaling. This process enables tissues to synchronize electrical activity, share metabolites, and propagate stress or survival signals. Its dysfunction or manipulation has been linked to clinically relevant outcomes, including protection against cisplatin-induced ototoxicity through cAMP transfer, inhibition by innate immune stimuli in corneal fibroblasts, remodeling during human coronavirus OC43 infection, and contributions to atherosclerosis and pain. Understanding the molecular players and regulatory inputs of gap junction-mediated transport is therefore essential for both basic cell biology and translational research.
• Enables direct cytoplasmic exchange of ions and small molecules between adjacent cells.
• Supports electrical and metabolic coupling in tissues.
• Mediates cAMP transfer that can prevent cisplatin-induced ototoxicity via cAMP/PKA/CREB.
• Can be inhibited by innate immune stimuli such as poly(I:C) in corneal fibroblasts.
• Is remodeled during human coronavirus OC43 infection in vitro.
• Modulates TGF-beta-induced epithelial-to-mesenchymal transition.
• Plays roles in immune system intercellular communication.
• Is implicated in pain mechanisms involving gap junctions and pannexins.
• Contributes to atherosclerosis through connexin-mediated processes.
• Provides a target for CRISPR-based functional dissection of connexin genes.
What Happens During gap junction-mediated intercellular transport?
Channel formation and docking
In simple terms: Two neighboring cells build matching half-channels that join to make a tunnel.
Gap junction-mediated intercellular transport begins with the assembly of connexin proteins into hemichannels (connexons) in the plasma membrane of each cell. When hemichannels from apposed cells dock, they form a complete gap junction channel that connects the cytoplasms of the two cells. This docking creates a fine cytoplasmic channel through which ions and other molecules can pass freely between the two cells.
Passage of ions and small molecules
In simple terms: Small molecules and ions travel directly from one cell to the next through the tunnel.
Once formed, gap junction channels permit the movement of substances between cells, including ions and other molecules, as defined for GO:1990349. This movement underlies electrical coupling and metabolic cooperation between adjacent cells. The process is distinct from transport across the extracellular space because it occurs directly between cytoplasms.
cAMP transfer and downstream signaling
In simple terms: A signaling molecule called cAMP can move between cells and activate protective pathways.
Gap junction-mediated intercellular communication of cAMP can prevent CDDP-induced ototoxicity via the cAMP/PKA/CREB pathway. This demonstrates that the transported substance can be a signaling molecule whose transfer activates a defined downstream cascade in recipient cells. The study links gap junction transport directly to a protective cellular outcome.
Inhibition and remodeling by external cues
In simple terms: Infections and immune signals can close or reshape these tunnels.
Poly(I:C) inhibits gap junction-mediated intercellular communication in cultured human corneal fibroblasts, showing that innate immune activation can suppress this transport process. Human coronavirus OC43 infection remodels connexin 43-mediated gap junction intercellular communication in vitro, indicating that pathogens can alter channel function. These findings illustrate that GO:1990349 is dynamically regulated by environmental and infectious stimuli.
Role in epithelial-to-mesenchymal transition
In simple terms: These tunnels influence whether cells change identity during fibrosis-like processes.
Gap junction-mediated intercellular communication affects TGF-beta-induced epithelial-to-mesenchymal transition. This places the transport process in the context of cell-state changes relevant to fibrosis and cancer progression. The study supports a functional contribution of gap junction communication to EMT.
Key Genes Involved in GO:1990349 gap junction-mediated intercellular transport
The genes and proteins most directly associated with GO:1990349 are connexins and related channel components, with connexin 43 being a prominent example in viral and signaling studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GJA1 (Connexin 43) | Forms gap junction channels; remodeled during HCoV-OC43 infection | Key model for viral remodeling of gap junction intercellular communication |
| GJB1 (Connexin 32) | Connexin family member contributing to gap junction channels | General gap junction biology and intercellular transport |
| GJB2 (Connexin 26) | Connexin family member contributing to gap junction channels | General gap junction biology and intercellular transport |
| GJB6 (Connexin 30) | Connexin family member contributing to gap junction channels | General gap junction biology and intercellular transport |
| GJC1 (Connexin 45) | Connexin family member contributing to gap junction channels | General gap junction biology and intercellular transport |
| GJD2 (Connexin 36) | Connexin family member contributing to gap junction channels | General gap junction biology and intercellular transport |
| PANX1 | Pannexin channel protein related to gap junction and pain mechanisms | Pain research involving gap junctions and pannexins |
| PRKACA | Catalytic subunit of PKA downstream of cAMP transferred via gap junctions | cAMP/PKA/CREB pathway in ototoxicity protection |
| CREB1 | Transcription factor activated downstream of cAMP/PKA signaling | cAMP/PKA/CREB pathway in ototoxicity protection |
| TGFB1 | Cytokine that induces EMT in a gap junction-sensitive manner | TGF-beta-induced EMT and gap junction communication |
| CDDP (cisplatin, not a gene) | Chemical agent causing ototoxicity modulated by gap junction cAMP transfer | Experimental ototoxicity model |
| Poly(I:C) (not a gene) | Innate immune stimulus that inhibits gap junction communication | Corneal fibroblast gap junction inhibition |
| HCoV-OC43 (not a gene) | Virus that remodels connexin 43-mediated communication | Viral remodeling of gap junction intercellular communication |
| Connexins (general family) | Form gap junction channels for intercellular transport | Core structural components of GO:1990349 |
| Pannexins (general family) | Channel proteins related to gap junction and pain biology | Pain mechanisms involving gap junctions and pannexins |
How Is gap junction-mediated intercellular transport Regulated?
Gap junction-mediated intercellular transport is regulated at multiple levels, including channel assembly, docking, and modulation by external cues. Innate immune stimulation with poly(I:C) inhibits gap junction-mediated intercellular communication in cultured human corneal fibroblasts, indicating regulation by immune signaling. Human coronavirus OC43 infection remodels connexin 43-mediated gap junction intercellular communication in vitro, showing pathogen-driven regulation. cAMP transfer through gap junctions activates the cAMP/PKA/CREB pathway, linking transported second messengers to downstream transcriptional regulation. TGF-beta-induced epithelial-to-mesenchymal transition is influenced by gap junction-mediated intercellular communication, suggesting regulation during cell-state transitions.
gap junction-mediated intercellular transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GJA1 (Connexin 43) | Viral remodeling of gap junction communication | HCoV-OC43 infection in vitro with connexin 43 readouts |
| Connexins (general) | Atherosclerosis | Vascular cell models with connexin manipulation |
| PRKACA/CREB1 pathway | Cisplatin-induced ototoxicity | cAMP/PKA/CREB reporter models with gap junction transport |
| TGFB1 pathway | Epithelial-to-mesenchymal transition | TGF-beta-treated epithelial cells with gap junction modulation |
| PANX1 | Pain | Pain-related cellular or animal models involving pannexins |
Ototoxicity and hearing protection
Gap junction-mediated intercellular communication of cAMP prevents CDDP-induced ototoxicity via the cAMP/PKA/CREB pathway. This links GO:1990349 directly to a clinically relevant toxicity model and suggests that enhancing cAMP transfer could be protective.
Viral infection and corneal innate immunity
Human coronavirus OC43 infection remodels connexin 43-mediated gap junction intercellular communication in vitro. Poly(I:C) inhibits gap junction-mediated intercellular communication in cultured human corneal fibroblasts, connecting innate immune activation to reduced coupling. Together these studies show that pathogens and immune stimuli can disrupt GO:1990349.
Atherosclerosis and vascular biology
Connexins have been implicated in atherosclerosis, where altered gap junction communication may contribute to vascular pathology. This places GO:1990349 within cardiovascular disease mechanisms.
Pain and EMT
Gap junctions and pannexins are involved in pain mechanisms, suggesting a role for intercellular transport in nociceptive signaling. Gap junction-mediated intercellular communication also affects TGF-beta-induced epithelial-to-mesenchymal transition, a process relevant to fibrosis and cancer.
From gap junction-mediated intercellular transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a connexin required for intercellular transport? | CRISPR knockout of the candidate connexin gene |
| Does a specific connexin mutation alter channel function? | Point-mutation knock-in of the connexin gene |
| Can a tagged connexin be tracked in live cells? | Tagged knock-in of the connexin locus |
| Does overexpression of a connexin enhance transport? | Overexpression cell model |
| Does cAMP transfer protect against cisplatin toxicity? | Gap junction-competent cells with cAMP/PKA/CREB readouts |
| Does infection remodel gap junction communication? | In vitro infection model with connexin 43 readouts |
How to Study the gap junction-mediated intercellular transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Dye transfer assay | Movement of small molecules between cells | Direct functional readout of gap junction-mediated transport |
| Electrical coupling measurement | Ion flow between cells | Assessment of gap junction channel function |
| cAMP/PKA/CREB reporter assay | Downstream signaling after cAMP transfer | Ototoxicity protection studies |
| Viral infection in vitro | Remodeling of connexin 43 communication | HCoV-OC43 studies |
| Poly(I:C) treatment | Inhibition of gap junction communication | Corneal fibroblast innate immune studies |
| TGF-beta EMT assay | Epithelial-to-mesenchymal transition | Fibrosis and cancer-related studies |
| Connexin expression analysis | Levels and localization of connexins | General gap junction biology |
Functional transport assays
Gap junction-mediated intercellular transport can be assessed by measuring the transfer of small molecules or ions between adjacent cells. Such assays directly report on the process defined by GO:1990349. They are used to test whether connexins or external cues alter coupling.
Signaling pathway readouts
Because cAMP transfer can activate the cAMP/PKA/CREB pathway, downstream phosphorylation and transcriptional readouts can be used to infer transport-dependent signaling. This approach links GO:1990349 to a defined molecular cascade.
Infection and immune stimulation models
In vitro infection with HCoV-OC43 and treatment with poly(I:C) are established ways to probe remodeling or inhibition of gap junction communication. These models connect GO:1990349 to host-pathogen and innate immune biology.
EMT and fibrosis-related assays
TGF-beta-induced EMT models can be combined with gap junction modulation to test whether intercellular transport influences cell-state transitions. This provides a disease-relevant context for GO:1990349.
How CRISPR Can Be Used to Study GO:1990349 gap junction-mediated intercellular transport
Knockout
CRISPR knockout of connexin genes can remove specific gap junction channels and test whether GO:1990349-dependent transport is lost. This is a direct way to establish causality for a candidate connexin.
Point Mutation
Point-mutation knock-in can introduce defined amino acid changes in connexins to dissect channel function without eliminating the protein. Such models help separate transport-dependent from transport-independent roles.
Knock-in
Tagged knock-in of connexin loci enables tracking of channel localization and dynamics in live cells. This supports mechanistic studies of gap junction assembly and docking.
Overexpression
Overexpression of connexins can enhance gap junction-mediated intercellular transport and test whether increased coupling alters downstream phenotypes. This complements loss-of-function approaches.
How EDITGENE Supports gap junction-mediated intercellular transport Research
Researchers studying gap junction-mediated intercellular transport-related genes often need to determine whether a candidate connexin or regulatory gene is causally involved in channel function, signaling, or disease phenotypes. EDITGENE provides CRISPR-based cell model services that enable such causal experiments in a controlled and reproducible manner.
Contact EDITGENE today to design your custom CRISPR model for gap junction-mediated intercellular transport research.
Frequently Asked Questions About gap junction-mediated intercellular transport
What is gap junction-mediated intercellular transport?
It is the movement of substances between cells via gap junctions, which are fine cytoplasmic channels connecting adjacent animal cells and allowing ions and other molecules to pass freely.
What is GO:1990349?
GO:1990349 is the Gene Ontology identifier for gap junction-mediated intercellular transport, a biological process.
What genes are involved in gap junction-mediated intercellular transport?
Connexin genes such as GJA1 (connexin 43) and other connexin family members form the channels, while signaling genes like PRKACA and CREB1 act downstream of transported cAMP.
How is gap junction-mediated intercellular transport regulated?
It is regulated by channel assembly and docking, by innate immune stimuli such as poly(I:C), by viral infection such as HCoV-OC43, and by signaling pathways including cAMP/PKA/CREB and TGF-beta.
What diseases are linked to gap junction-mediated intercellular transport?
It has been linked to cisplatin-induced ototoxicity, viral infection, corneal innate immunity, atherosclerosis, pain, and epithelial-to-mesenchymal transition.
Can gap junctions transfer cAMP between cells?
Yes, gap junction-mediated intercellular communication of cAMP can occur and can prevent CDDP-induced ototoxicity via the cAMP/PKA/CREB pathway.
Does coronavirus infection affect gap junctions?
Human coronavirus OC43 infection remodels connexin 43-mediated gap junction intercellular communication in vitro.
How can I study gap junction-mediated intercellular transport with CRISPR?
CRISPR knockout, point-mutation, knock-in, and overexpression models of connexin genes allow causal testing of channel function and downstream phenotypes.
What methods measure gap junction-mediated intercellular transport?
Dye transfer assays, electrical coupling measurements, and downstream signaling readouts such as cAMP/PKA/CREB reporters are commonly used.
Why is gap junction-mediated intercellular transport important for immunity?
Gap junction-mediated intercellular communication operates in the immune system and can be inhibited by innate immune stimuli such as poly(I:C) in corneal fibroblasts.
Conclusion
GO:1990349, gap junction-mediated intercellular transport, is a core biological process that enables direct cytoplasmic exchange of ions and small molecules between adjacent animal cells through connexin-based channels. Its roles span immune communication, ototoxicity protection, viral remodeling, atherosclerosis, pain, and EMT, making it a high-value target for mechanistic and translational research. CRISPR-based knockout, point-mutation, knock-in, and overexpression models provide the causal tools needed to dissect connexin function and regulation in this process.
References
- 1. Hervé JC et al.. 2013. Gap-junction-mediated cell-to-cell communication.. Cell Tissue Res 352(1):21-31 PMID: 22940728
- 2. Kim YJ et al.. 2021. Gap Junction-Mediated Intercellular Communication of cAMP Prevents CDDP-Induced Ototoxicity via cAMP/PKA/CREB Pathway.. Int J Mol Sci 22(12) PMID: 34199197
- 3. Zheng H et al.. 2020. Inhibition of Gap Junction-Mediated Intercellular Communication by Poly(I:C) in Cultured Human Corneal Fibroblasts.. Curr Eye Res 45(9):1043-1050 PMID: 32078434
- 4. Karmakar S et al.. 2024. Human coronavirus OC43 infection remodels connexin 43-mediated gap junction intercellular communication in vitro.. J Virol 98(7):e0047824 PMID: 38819132
- 5. Fukuda S et al.. 2019. Effect of gap junction-mediated intercellular communication on TGF-β induced epithelial-to-mesenchymal transition.. Biochem Biophys Res Commun 508(3):928-933 PMID: 30545634
- 6. Neijssen J et al.. 2007. Gap junction-mediated intercellular communication in the immune system.. Prog Biophys Mol Biol 94(1-2):207-18 PMID: 17467043
- 7. Spray DC et al.. 2019. Gap junctions, pannexins and pain.. Neurosci Lett 695:46-52 PMID: 28647288
- 8. Chadjichristos CE et al.. 2006. Connexins in atherosclerosis.. Adv Cardiol 42:255-267 PMID: 16646596
